A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™
Authors
Sai Prasad (ORCID: https://orcid.org/0000-0002-5546-3673)
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™
Sai Prasad, Abhishek Chavan, Savita Verma, Raches Ella et al.
Citations
1 citations
Journal
Vaccine
Topics
Vibrio bacteria research studies
Field-Weighted Citation Impact (FWCI)
1.80
article
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (IN), Nagpur Institute of Technology (IN), Goa Dental College and Hospital (IN), Narayana Health (IN), Bharat Biotech (India) (IN), Institute for Biomedicine (IT), King George Hospital (IN), All India Institute of Medical Sciences (IN), University of Gothenburg (SE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™ — Sai Prasad, Abhishek Chavan, et al. · Vaccine (2025) | TGRS Research Map | TGRS